I may be completely wrong but It wouldn’t surprise me if they have managed timing of likely garadacimab approval announcement to coincide with csl112 results release. That way any mixed news on csl112 will be obscured by the good news on garadacimab.
all around results release date late Feb.
Garadacimab and csl112
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.16 |
Change
-0.770(0.25%) |
Mkt cap ! $148.4B | |||
| Open | High | Low | Value | Volume |
| $309.31 | $309.89 | $305.94 | $474.0M | 1.557M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $307.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.30 | 1568 | 3 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |